6 results
8-K
EX-99.1
APTX
Aptinyx Inc.
16 Jan 19
Aptinyx Reports Top-line Results from Phase 2 Clinical Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
8:00am
execution and achievements on these programs in 2019 and 2020.”
“We are in the midst of a major societal and healthcare crisis in the treatment of pain
424B4
APTX
Aptinyx Inc.
21 Jun 18
Prospectus supplement with pricing info
5:18pm
-label pharmacotherapies, people with PTSD often self-medicate with alcohol and recreational drugs, perpetuating societal impacts of the disorder
S-1/A
APTX
Aptinyx Inc.
11 Jun 18
IPO registration (amended)
12:00am
to approved and off-label pharmacotherapies, people with PTSD often self-medicate with alcohol and recreational drugs, perpetuating societal impacts
S-1
APTX
Aptinyx Inc.
23 May 18
IPO registration
4:53pm
. In addition to approved and off-label pharmacotherapies, people with PTSD often self-medicate with alcohol and recreational drugs, perpetuating societal
DRS/A
zbl442l
4 May 18
Draft registration statement (amended)
12:00am
- Prev
- 1
- Next